Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Ogulcan Ozdemir. NAION during incretin-based therapy: an optic nerve head still adapted to hypertension. // Eye. – 2026. – DOI: 10.1038/s41433-026-05032-9. – URL: https://www.nature.com/articles/s41433-026-05032-9
Ogulcan Ozdemir (2026). NAION during incretin-based therapy: an optic nerve head still adapted to hypertension. Eye. https://doi.org/10.1038/s41433-026-05032-9
Ogulcan Ozdemir. “NAION during incretin-based therapy: an optic nerve head still adapted to hypertension.” Eye, 2026. doi:10.1038/s41433-026-05032-9.
@article{Ozdemir2026,
title = {NAION during incretin-based therapy: an optic nerve head still adapted to hypertension},
author = {Ozdemir, Ogulcan},
journal = {Eye},
year = {2026},
doi = {10.1038/s41433-026-05032-9},
url = {https://www.nature.com/articles/s41433-026-05032-9}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’
Nature Reviews Gastroenterology & Hepatology, Published online: 19 November 2026; doi:10.1038/s41575-026-01289-3 Interferon signalling key to KRAS-targeted therapy response in pancreatic cancer